Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Zoetis Inc Cl A (ZTS)

Zoetis Inc Cl A (ZTS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 77,681,456
  • Shares Outstanding, K 475,145
  • Annual Sales, $ 6,260 M
  • Annual Income, $ 1,500 M
  • 60-Month Beta 0.71
  • Price/Sales 12.32
  • Price/Cash Flow 35.69
  • Price/Book 25.82
Trade ZTS with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.89
  • Number of Estimates 9
  • High Estimate 1.00
  • Low Estimate 0.83
  • Prior Year 0.94
  • Growth Rate Est. (year over year) -5.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
158.95 +0.99%
on 10/07/20
168.96 -5.00%
on 10/12/20
-0.32 (-0.20%)
since 09/25/20
3-Month
143.74 +11.68%
on 07/27/20
168.96 -5.00%
on 10/12/20
+16.30 (+11.30%)
since 07/24/20
52-Week
90.14 +78.08%
on 03/23/20
168.96 -5.00%
on 10/12/20
+36.16 (+29.08%)
since 10/25/19

Most Recent Stories

More News
Zoetis to Participate in the Credit Suisse 2020 Virtual Healthcare Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Credit Suisse 2020 Virtual Healthcare Conference on Tuesday, Nov. 10, 2020. Glenn David, Executive Vice President and Chief Financial Officer, will represent...

ZTS : 160.82 (-1.63%)
Top Analyst Reports for Netflix, Lockheed Martin & Zoetis

Top Analyst Reports for Netflix, Lockheed Martin & Zoetis

ZTS : 160.82 (-1.63%)
TEAM : 205.97 (-1.21%)
NFLX : 484.39 (-0.80%)
MRNA : 69.48 (-1.49%)
LMT : 363.65 (-2.85%)
ITUB : 4.56 (+1.56%)
Zoetis Inc Set to Possibly Pullback After Yesterday's Rally of 1.93%

Zoetis Inc (NYSE:ZTS) traded in a range yesterday that spanned from a low of $162.25 to a high of $164.61. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $163.22...

ZTS : 160.82 (-1.63%)
Shares of ZTS Up 41.3% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Zoetis Inc (NYSE:ZTS) on March 26th, 2020 at $114.10. In approximately 7 months, Zoetis Inc has returned 41.26% as of today's recent price of $161.18.

ZTS : 160.82 (-1.63%)
Is Zoetis (ZTS) Stock Outpacing Its Medical Peers This Year?

Is (ZTS) Outperforming Other Medical Stocks This Year?

ZTS : 160.82 (-1.63%)
Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again

Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

ZTS : 160.82 (-1.63%)
Zoetis Inc Up 47.0% Since SmarTrend Uptrend Call (ZTS)

SmarTrend identified an Uptrend for Zoetis Inc (NYSE:ZTS) on March 26th, 2020 at $114.10. In approximately 7 months, Zoetis Inc has returned 47.02% as of today's recent price of $167.75.

ZTS : 160.82 (-1.63%)
Is Aphria a Buy Under $7?

Certain industries are outperforming as the market is anticipating a change in regulation under a new political regime. Current polling shows that Democrats are favored to take control of the Senate, and...

APHA : 4.56 (+0.22%)
ABT : 108.77 (+0.91%)
NVO : 69.70 (-1.47%)
ZTS : 160.82 (-1.63%)
3 "Strong Buy" Pet Stocks That Will Continue to Soar

Pet adoption has increased in 2020 and the amount of money being spent on animals continues to soar. Therefore, it's prudent to consider adding Zoetis (ZTS), IDEXX Laboratories (IDXX) and Freshpet (FRPT)...

ZTS : 160.82 (-1.63%)
IDXX : 429.30 (-0.08%)
FRPT : 116.06 (-1.48%)
3 Pharmaceutical Stocks to Buy & Hold for the Rest of the Year

As COVID cases exceed 7.5 million in the US and most states seeing an increase, fears of the second wave are rising. The demand for treatment or a vaccine is higher than ever. That fear and an aging population...

ABT : 108.77 (+0.91%)
NVO : 69.70 (-1.47%)
ZTS : 160.82 (-1.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.

See More

Key Turning Points

2nd Resistance Point 165.81
1st Resistance Point 164.65
Last Price 160.64
1st Support Level 162.29
2nd Support Level 161.09

See More

52-Week High 168.96
Last Price 160.82
Fibonacci 61.8% 138.85
Fibonacci 50% 129.55
Fibonacci 38.2% 120.25
52-Week Low 90.14

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar